David Baldwin

Summary

Affiliation: University of Southampton
Country: UK

Publications

  1. doi request reprint Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis
    David Baldwin
    Faculty of Medicine, University Department of Psychiatry, University of Southampton Academic Centre, Southampton SO14 3DT, UK
    BMJ 342:d1199. 2011
  2. ncbi request reprint Placebo-controlled studies in depression: necessary, ethical and feasible
    David Baldwin
    University Department of Mental Health, Royal South Hants Hospital, Brintons Terrace, Southampton, UK
    Eur Arch Psychiatry Clin Neurosci 253:22-8. 2003
  3. ncbi request reprint Short-term treatment with hypnotic drugs for insomnia: going beyond the evidence
    David Baldwin
    Clinical Neuroscience Division, University of Southampton, Southampton, UK
    J Psychopharmacol 19:134-5. 2005
  4. ncbi request reprint Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine
    David Baldwin
    Clinical Neuroscience Division, School of Medicine, University of Southampton, Southhampton, UK
    J Psychopharmacol 20:91-6. 2006
  5. ncbi request reprint Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial
    Tony Kendrick
    Primary Medical Care Group, Community Clinical Sciences Division, University of Southampton Medical School, Aldermoor Health Centre, Southampton SO16 5ST, UK
    Br J Psychiatry 188:337-45. 2006
  6. ncbi request reprint Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670
    David Baldwin
    Clinical Neuroscience Division, University of Southampton, Southampton, UK
    J Psychopharmacol 22:55-63. 2008

Detail Information

Publications6

  1. doi request reprint Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis
    David Baldwin
    Faculty of Medicine, University Department of Psychiatry, University of Southampton Academic Centre, Southampton SO14 3DT, UK
    BMJ 342:d1199. 2011
    ..To appraise the evidence for comparative efficacy and tolerability of drug treatments in patients with generalised anxiety disorder...
  2. ncbi request reprint Placebo-controlled studies in depression: necessary, ethical and feasible
    David Baldwin
    University Department of Mental Health, Royal South Hants Hospital, Brintons Terrace, Southampton, UK
    Eur Arch Psychiatry Clin Neurosci 253:22-8. 2003
    ..Placebo-controlled studies of new antidepressants are justified, both scientifically and ethically; restrictions on placebo-controlled investigations will hinder the arrival of more efficacious and better tolerated antidepressants...
  3. ncbi request reprint Short-term treatment with hypnotic drugs for insomnia: going beyond the evidence
    David Baldwin
    Clinical Neuroscience Division, University of Southampton, Southampton, UK
    J Psychopharmacol 19:134-5. 2005
  4. ncbi request reprint Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine
    David Baldwin
    Clinical Neuroscience Division, School of Medicine, University of Southampton, Southhampton, UK
    J Psychopharmacol 20:91-6. 2006
    ..Sexual function and satisfaction in depressed patients improves during double-blind acute treatment with reboxetine or paroxetine, but this improvement is greater and more rapid with reboxetine...
  5. ncbi request reprint Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial
    Tony Kendrick
    Primary Medical Care Group, Community Clinical Sciences Division, University of Southampton Medical School, Aldermoor Health Centre, Southampton SO16 5ST, UK
    Br J Psychiatry 188:337-45. 2006
    ..The cost-effectiveness of tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) has not been compared in a prospective study in primary care...
  6. ncbi request reprint Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670
    David Baldwin
    Clinical Neuroscience Division, University of Southampton, Southampton, UK
    J Psychopharmacol 22:55-63. 2008
    ..3%). Double-blind treatment with VML-670 offered no significant advantage over placebo on the primary outcome measure in the overall sample. Further studies may be warranted in larger groups of male patients with sexual dysfunction...